Index GRI

1. Strategy and Analysis

GRI Description Webpagina 
1,1A declaration from the people with the highest decision-making powers in the organisation- Report to Society
- Strategy
1.2Description of important effects, risks and opportunities- Frame of reference
- Chairman's letter - p 2
- Successes and Challenges - p 4

    2. Organizational Profile

    GRI Description Webpage 
    2,1Name of the organisation- About Janssen 
    2.2Most prominent brands, products and/or services. Operational structure of the organisation, including divisions, operating companies, subsidiaries and partnerships- Company profile
    - Organization Profile, p 9
    2.4Location of the organisation’s headquarters- Company profile
    - Organization Profile - p 9
    2.5The number of countries in which the organisation operates and the names of countries with either large-scale operations, or with specific relevance for the sustainability issues discussed in the report- Company profile

    - Organization Profile - p 9
    - Form 10K annual Report: Item 2, Properties
    - Form 10K Annual Report: Exhibit 21, Subsidiaries

    2.6Ownership structure and legal form- Company profile
    - Frame of reference
    2.7Sales markets (geographic spread, sectors served and types of clients/beneficiaries)- Organization Profile - p 9
    2.8Size of the reporting organisation- Company profile
    2.9Significant changes during the reporting period concerning size, structure or ownershipNVT
    2.10Highlights recognised during the reporting period- Annual report

      3. Report Parameters

      GRIDescription Webpage 
      3,1Reporting period to which the information provided relates- Frame of reference
      3.2Date of the most recent reportJune 2013
      3.3Reporting cycle- Frame of reference
      3.4Contact point for questions on the report or its contents- Contact
      3.5Process for determining the contents of the report- Frame of reference
      3.6Segmentation of the report- Frame of reference
      3.7State any specific limitations for the scope or segmentation of the report- Frame of reference
      3.8Basis for reporting on partnerships, subsidiaries in Partial ownership, rented facilities, outsourced activities or other entities, which significantly affect the comparability between different reporting periods or reporting organisations- Frame of reference
      3.9The techniques and calculation principles for data measurements, including assumptions used for estimates and the techniques applied to the composition of the indicators and other information in the report- Frame of reference
      3.1Explanation of the consequences of any reformulation of previously provided information (e.g. mergers or acquisitions, change of reference year or reporting period and changes relating to the nature of the activities or the methods of measurement)- Frame of reference
      3.11Significant changes in connection with the previous reporting period concerning scope, segmentation of the report- Frame of reference
      3.12Table showing where in the report the standard sections of the information provided can be found- This page
      3.13Policy and current practice with respect to obtaining external assurance on the report- Frame of reference

        4. Governance, Commitments and Engagement

        GRIDescription Webpage 
        4,1The management structure of the organisation, including committees under the highest governance body and responsible for specific tasks, such as setting strategy or the supervision of the organisation- Governance - p 36
        4,2State whether the chairman of the highest governance body also has a management position (and, if so, his or her position in the context of the organisation and the reasons for this situation)- Governance, Governance Structure - p 37
        4,3For organisations that have a single management structure: state the number of independent and/or non-executive members of the highest governance body- Governance, Governance Structure - p 37
        4,4Mechanisms that provide shareholders and employees the opportunity to make recommendations to or participate in the highest governance body- Governance, Governance Structure - p 37
        4,5A link between remuneration for members of the highest governance body, top managers and managers (including severance schemes) and the performance of the organisation (including social and environmentally related performance)Notice of Annual Meeting and Proxy Statement - p 34
        4,6Processes with which the highest governance body ensures that conflicts of interest are avoided. Process for determining the qualifications and expertise of the members of the highest governance body and for the management of the organisation’s strategy concerning economic, environmental and social subjectsJohnson & Johnson 2014 Proxy Statement: nominating and governance committee
        4,8Internally developed mission or principles statements, codes of conduct and principles that are important for the economic, environmental and social performance, stating the extent to which they have been implementedCitizenship & Sustainability - p 11
        - Strategic Leadership, p - 29
        - Strategy
        4,9Procedures of the highest governance body for supervising the taking inventory and management by the organisation of economic, environmentally related and social performance, including relevant risks and opportunities and compliance with or conforming to internationally agreed standards, codes of conduct and principlesCitizenship & Sustainability - p 11
        - Strategic Leadership, p - 29
        4,1Processes for the evaluation of the highest governance body’s own performance, especially concerning economic, environmentally related and social performance- Johnson & Johnson 2014 Proxy Statement: Corporate Governance
        4,11Explanation of how the precautionary principle is applied by the reporting organisation- UNGC, Principle 7 - p 96
        - Environmental Responsibility - p 77
        4,12Externally developed economic, environmentally related and social charters, principles or other initiatives that the organisation endorses- Governance: External Commitments - p 38
        4,13Membership of associations (such as sector associations) and/or national/international interest groups- Footnote (1)
        4,14List of groups of stakeholders that the organisation has involved- Referentiekader (Stakeholders)
        Stakeholder Engagement - p 62
        - Stakeholder Engagement
        4,15Basis for taking inventory and selection of stakeholders that must be involved. Approach for the involvement of stakeholders, including the frequency of this for each type and group of stakeholders- Frame of reference (Stakeholders)
        B33
        4,17The key subjects and issues that have been raised by the involvement of stakeholders and how the organisation has responded to these, including via its reporting- Frame of reference (Stakeholders)
        B33
        • (1)

          Membership of associations (such as trade associations) 
          and/or national/international interest groups: AmCham, BCLAS, Business & Society, EFPIA/IFPMA, Essenscia, Essenscia Vlaanderen, EU Innovation Forum, Flanders Synergy, FlandersBio, HST, Industrieraad Vlaanderen, Innovative Medicines Initiative (IMI), Kauri, MCB Forum, pharma.be, Plan C, STEM platform, Strategische Projectorganisatie Kempen (SPK), VKW, Vlaamse Raad voor Wetenschap en Innovatie, VOKA, Voka Kempen 

        Management Approach 

        GRIDescriptionWebpage 
         Economy - Key figures - Other economic facts- Key figures
        - Economic policy
        - Innovative therapeutical solutions
        - Open innovation model
        - Partnerships
        - Investment policy
        Ecological sustainability - Green policy
        - Green initiatives
        - Reduction of Energy consumption
        - Energy-saving initiatives
        - Sustainable waste management
        - Sustainable waste management at the sites
        - Fewer pharmaceutical substances in the living environment
        - Stop using useless packaging
        - Reducing consumption of raw materials
        - Green chemistry and technology
        - Chem21 programme
        - Reducing water consumption
        - Reducing emissions
        - More biodiversity
        - Sustainable enterprising suppliers
        - Green recognitions
        - GRIdata
        Prevention policy
        Farma-specifiekResearch & Development- Ethical drug research
        - Animal testing
        - Safety in research
        - Innovation in clinical research
        - Opportunities for Research & Development
        - R&D acknowledgements
        Farma-specifiekJanssen Supply Chain- Chemical production in Geel
        - Pharmaceutical production in Geel/ Olen
        - Quality of production
        - Lean manufacturing: slim production
        - Janssen wins 2013 Supply Chain Award.
        Farma-specifiekPartners- Exascience
        - EMIF
        - HST
        - Stellar
        - Health2wealth
        Social sustainability- Employees
        - Attracting and developing talents
        - monitoring and guidance in talent development
        - Sustainable use of talents
        - Inspiring and pleasant working environment
        - Programmes concerning mental and physical health
        - Result-driven culture
        - Excellent operational service provision
        - Highlights of 2013 Credo survey
        - Safety and prevention
        - GRI-data
        Labour Practices and Decent Work - Social sustainability
        - Labor Practices and Workforce, page 52 and Online
        Human Rights - Human Rights, page 42 and Online
        Society - Innovative access strategies
        - Projects for the community
        - Move for Africa 2013
        - Janssen Cares! Our Credo in action
        - Labyrinth Psychotica: better understanding of psychosis
        - The first open-door day for many years
        - Neighbourhood residents are important
        - VzW de Schakel receives financial support due to our prevention share
        - Start of the Corporate Social Responsibility project
        Product responsibility - Supply Chain
        - Integrity
        - Reducing consumption of raw materials

          Economic Aspects

          BeschrijvingBehandelingWebpagina 
          EC1
          - Kwaliteit van productie 
          - Duurzaam ondernemende leveranciers
          - Samenleving
          - Samenwerkingen : investeringsklimaat farma-industrie verbeteren
          - Kerncijfers

            Environmental Aspects

            GRI Description TreatmentWebpage 
            EN3Direct energy consumption by primary energy sourceFull- GRI data
            EN4 Indirect energy consumption by primary energy sourceFull- GRI data
            EN5 Energy saved due to conservation and efficiency improvementsFull- Energy-saving initiatives
            EN6 Initiatives to provide energy-efficient or renewable energy based products and services, and reductions in energy requirements as a result of these initiatives.Full- Energy-saving initiatives
            EN7 Initiatives to reduce indirect energy consumption and reductions already achievedFull- Energy-saving initiatives
            EN8 Total water extraction for each source Full- GRI data
            EN10 Percentage and total volume of recycled and reused water Full- GRI data
            EN12 Description of significant effects of activities, products, and services on biodiversity in protected areas and areas of high biodiversity value outside protected areasPartial- Biodiversity
            EN14 Strategies, current measures, and future plans for managing the effects of the biodiversityPartial- More biodiversity
            EN16 Total direct and indirect greenhouse gas emissions by weightFull- GRI data
            EN17 Other relevant indirect greenhouse gas emissions by weight Partial- Reducing emissions
            EN18 Initiatives to reduce greenhouse gas emissions and reductions achievedFull- Energy-saving initiatives
            - Reducing emissions
            EN19 Emissions of ozone-depleting substances by weightFull- GRI data
            EN20 NOx, SOx and other significant air emissions by type and weightPartial- GRI data
            EN21 Total water discharge by quality and destinationFull- GRI data
            EN22 Total weight of waste by type and removal methodFull- GRI data
            EN24Quantity of waste that is transported across frontiersFull- GRI data
            EN26Initiatives to mitigate ecological effect attributable to products and services (as well as the effect of this mitigation)Full- Sustainable waste management at the sites
            - Less pharmaceutical substances in the living environment
            - Sustainably enterprising suppliers
            - Restraint on useless packaging
            EN28 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with environmental laws and regulationsFull- GRI data
            EN29 Significant environmental effects of transporting products and other goods and materials used for the organisation’s operations, and transporting members of the workforcePartial- Reducing emissions
            - Sustainably enterprising suppliers

              Social Aspects

              Labor Practices and Decent Work

              GRI Description TreatmentWebpage 
              LA1Total workforce by type of work, employment contract, and regionPartial- GRI data
              LA2 Total number and rate of employee turnover by age group, gender, and regionPartial- GRI data
              LA4 Percentage of employees covered by collective bargaining agreementsFull- GRI data
              LA7 Figures for injuries, occupational diseases, lost days, and absenteeism, and number of work-related fatalities for each regionPartial- GRI data
              LA8 Education, training, advisory, prevention and risk management programmes for employees, their families or neighbouring people in connection with serious illnessesFull- Safety and prevention
              - VzW de Schakel  receives financial support because of our prevention share
              LA10 Average number of hours of training per year per employee, broken down by employee categoryPartial- GRI data
              LA 11 Programmes for competence management and lifelong learning that guarantee the continued employability of employees and assist them in managing the completion of their careersFull- Monitoring and guidance in talent development
              LA13 Composition of governance bodies and breakdown of employees per category, according to gender, age group, social minority group membership, and other indicators of diversityPartial- GRI data

                Human Rights  

                GRI Description TreatmentWebpage 
                HR1Percentage and total number of significant investment agreements that include human rights clauses or that have undergone screening for compliance with human rightsPartial- Human Rights, page 42 and Online
                HR2 Percentage of important suppliers and customers that have undergone screening for compliance with human rights and measures takenPartial- Sustainably enterprising suppliers
                - Human Rights, pages 43–44
                - Supply Chain & Supply Chain Management, page 39
                - Labor Practices & Work Force, page 52
                HR3 Total hours of employee training on policies and procedures concerning aspects of human rights that are relevant for the activities, including the percentage of employees trainedPartial- Human Rights, pages 43–44
                HR4 Total number of cases of discrimination and the measures takenPartial- Human Rights, pages 43–44
                HR5 Activities identified in which the right to exercise freedom of association and collective bargaining could be at significant risk, and measures taken to support these rights. Activities identified in which there is a significant risk of cases of child labour, and the measures taken that focus on eliminating child labourPartial- Human Rights, pages 43–44
                HR7 Activities identified in which there is a significant risk of cases of forced labour, and the measures taken that focus on eliminating forced labourPartial- Human Rights, pages 43–44
                - Supply Chain & Supply Chain Management, page 39
                - Labor Practices & Work Force, page 52

                  Society

                  GRIDescription TreatmentWebpage 
                  SO1 Nature, scope, and effectiveness of all the programmes and methods that assess and manage the effects of activities on communities, including establishment, activities, and departureFull- Ethical Performance; Anti-Corruption, pages 32-34
                  SO2 Percentage and total number of business units analysed for risks related to corruption Partial- Integrity
                  - Ethical Performance; Anti-Corruption, pages 32-33
                  - Human Rights; Assessment Process, page 40
                  SO3 Percentage of employees trained in the organisation’s anti-corruption policies and proceduresFull- Integrity
                  SO4 Measures taken as a result of cases of corruptionFull- Ethical Performance; Ethical Marketing, page 34
                  SO8 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with laws and regulationsPartial- Compliance; Compliance with Laws & Regulations, page 34

                    Product Responsibility 

                    GRIDescription TreatmentWebpage 
                    PR1 Lifecycle stages in which the effects of products and services for health and safety are assessed with a view to improvement and the percentage of important product and service categories that are subject to such proceduresPartial- Pharmacovigilance
                    PR6 Programmes for the compliance with laws, standards and voluntary codes related to marketing communications, including advertising, promotion and sponsoringFull- Responsible marketing and communication 
                    PR (pharma-specific)Quality and safetyPartial- Innovation in clinical research
                    - Quality of production
                    PR (pharma-specific)Health & Compliance (responsible marketing)Full - our Credo
                    - Responsible marketing and communication
                    PR (pharma-specific)(Honest) pricing (access to medicines)Full- Innovating entrance strategies
                    - From molecule to medicine
                    PR (pharma-specific)InnovationFull- Strategy
                    - Open innovation model
                    - Innovative therapeutic solutions
                    - Innovation in clinical research
                    - Collaborations   
                    PR (pharma-specific)Compliance and ethics Full- Integrity
                    - Animal testing
                    PR (pharma-specific)R & DFull- Research & development
                    - Open innovation model
                    - Innovative therapeutic solutions